Suchergebnisse - "Shinoda, Masahiro"

PubPharm (13)

1

A case of reinfection with a different variant of SARS-CoV-2: case report

enthalten in: The Egyptian Journal of Internal Medicine | 2023

von Shimada, N. | Shinoda, M. | Takei, H. | +7

2

A case of reinfection with a different variant of SARS-CoV-2: case report

enthalten in: The Egyptian Journal of Internal Medicine | 2023

von Shimada, N. | Shinoda, M. | Takei, H. | +7

3

A case of reinfection with a different variant of SARS-CoV-2 : case report

enthalten in: The Egyptian journal of internal medicine | 2023

von Shimada, N. | Shinoda, M. | Takei, H. | +7

4

Possibility of underestimation of COVID-19 prevalence by PCR and serological tests

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2022

von Ota, S. | Sugawa, S. | Suematsu, E. | +3

5

A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

enthalten in: BMC medicine | 2022

von Kinoshita, T. | Shinoda, M. | Nishizaki, Y. | +11

ErratumIn: BMC Med. 2022 Dec 8;20(1):478. - PMID 36482439

6

A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

enthalten in: BMC medicine | 2022

von Kinoshita, T. | Shinoda, M. | Nishizaki, Y. | +11

7

A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

enthalten in: BMC medicine | 2022

von Kinoshita, T. | Shinoda, M. | Nishizaki, Y. | +11

8

Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants : An interim report of phase 2/3, randomized, observer-blinded, noninferiority study

enthalten in: Vaccine | 2022

von Shinkai, M. | Sonoyama, T. | Kamitani, A. | +8

9

Longitudinal Analysis of Neutralizing Potency against SARS-CoV-2 in the Recovered Patients after Treatment with or without Favipiravir

enthalten in: Viruses | 2022

von Shinada, K. | Sato, T. | Moriyama, S. | +8

10

Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy : A Randomized, Phase III Clinical Trial

enthalten in: Infectious diseases and therapy | 2021

von Shinkai, M. | Tsushima, K. | Tanaka, S. | +36